Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04782193
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-02-26
Brief Title:
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in RelapsedRefractory B Cell Lymphoma
Sponsor:
Chongqing Precision Biotech Co Ltd
Organization:
Chongqing Precision Biotech Co Ltd
Organization Data
Organization:
Chongqing Precision Biotech Co Ltd
Class:
INDUSTRY
Study ID:
PBC026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chongqing Precision Biotech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None